In terms of genetic susceptibility, female BMPR2 mutation carriers were more than twice as likely to develop PAH compared to male carriers (27); in a large cohort of individuals with BMPR2 mutations, approximately 70% of the affected population were women (28). This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.